Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 3, 2004

View Archived Issues

Gusperimus shows efficacy in SLE-associated glomerulonephritis

New atherosclerosis vaccine developed by GSK team

New vitamin D analogues and their use in bone diseases, cancer, etc.

Novel Src kinase inhibitors covered by AstraZeneca patent

New factor Xa inhibitors in early development at Boehringer Ingelheim

New CD80 antagonists and their use claimed by Avidex

New phenylsulfonamide-based gamma-secretase inhibitors and their use in AD

New factor XIa inhibitors identified by BMS researchers

New Chk1 kinase inhibitors under study at Abbott

Novel syncretic antiarthritic agents by CombinatoRx

Novel quinoxaline topoisomerase I inhibitor

Novel proteasome inhibitor shows efficacy against human prostate carcinoma in vitro

NovaDel Pharma licenses lingual ondansetron spray to Hana Biosciences

Oxford BioMedica and Arius Research extend cancer collaboration

Six months additional U.S. market exclusivity for Adderall XR

Takeda submits Actoplus Met NDA for type 2 diabetes

New oral solution of Levaquin approved

Protein Sciences cleared to begin phase II/III FluBlok study

Preclinical data on the antimicrobial activity of PPI-0903 reported at ICAAC

Aastrom signs diabetic limb ischemia trial agreement

Tipranavir/ritonavir shows antiviral efficacy in advanced HIV disease

Effective management of postoperative dental pain achieved with cimicoxib

Dosing commences in phase IIIb study of rhIGF-1 for primary IGF-1 deficiency

Approvable letter for Arcoxia

STTR grant for PET imaging efforts at Attenuon

Good gastrointestinal safety profile reported for etoricoxib in OA patients

Plexxikon and Wyeth team up to develop PPAR modulators

New Broad-Novartis Diabetes Initiative for type 2 diabetes

Eisai reacquires ravuconazole rights

Partial clinical hold lifted from Stanate

Priority review for Temodar sNDA

Update on the pharmacokinetics and antibacterial activity of doripenem

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...